As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the construction and maintenance services industry, including Construction Partners (NASDAQ:ROAD) and its peers.

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at La-Z-Boy (NYSE:LZB) and its peers.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Stratasys (NASDAQ:SSYS) and the rest of the custom parts manufacturing stocks fared in Q3.

(Bloomberg) -- Asian stocks reliant on exports, ranging from Japanese carmakers to Chinese e-commerce firms, nosedived after US President Donald Trump unleashed his first wave of tariffs, signaling the beginning of a new round of global trade war.Most Read from BloombergNew York’s First ‘Passive House’ School Is a Model of Downtown DensityWhen French Communists Went on a Brutalist Building BoomTrump Paves the Way to Deputize Local Police on ImmigrationHow the 2025 Catholic Jubilee Is Reshaping R

(Bloomberg) -- Chinese equities listed in Hong Kong outperformed their Asian peers as gains in tech heavyweights countered the negative impact of a new US tariff on China.Most Read from BloombergNew York’s First ‘Passive House’ School Is a Model of Downtown DensityWhen French Communists Went on a Brutalist Building BoomTrump Paves the Way to Deputize Local Police on ImmigrationHow the 2025 Catholic Jubilee Is Reshaping RomeHistoric London Elevator Faces Last Stop in Labour’s Housing PushThe Hang

Capital One’s $35.3 billion acquisition of Discover could close as early as February. It has the potential to reshape the credit card business.

On Monday, Asian investors finally got to digest a week's worth of bad news.

US stock futures pointed to sharp losses for the major indexes, as Wall Street showed the effects of President Donald Trump’s announcement of tariffs.

(Bloomberg) -- A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to address concerns over its business in China than on its earnings report alone.Most Read from BloombergNew York’s First ‘Passive House’ School Is a Model of Downtown DensityWhen French Communists Went on a Brutalist Building BoomTrump Paves the Way to Deputize Local Police on ImmigrationHow the 2025 Catholic Jubilee Is Reshaping RomeHistoric London Elevator Faces

Whatever investors expected from Donald Trump's tariff threats, or from the target countries' responses, they may have ended up with more than they bargained for. Equity indexes met with aggressive selling in Asia and looked headed for steep drops globally, based on futures prices for the U.S. S&P 500 and pan-European STOXX 50. Some investors had expected that Trump would water down his threat of 25% levies on neighbours Canada and Mexico, and possibly put off additional duties on China - or that, if the tariffs went ahead as stated, they would be quietly accepted.